Skip to main content
Clinical Trials/NCT03627650
NCT03627650CompletedNot Applicable

Fat Grafting in Immature Skin-grafted Burn Scars: a Randomised Controlled Clinical Trial

University Hospital, Ghent0 sites15 target enrollmentStarted: May 1, 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
15
Primary Endpoint
improvement of scar quality by physiological testing with cutometer

Study Overview

Brief Summary

fat grafting in human skin-grafted immature burn scars histological, clinical and photographic follow-up

Detailed Description

Objective

A randomised clinical trial was performed to determine the effect of autologous fat grafting on scar formation in early skin-grafted deep burn wounds.

Methods: Included patients received split-thickness skin grafting procedures for deep burn wounds less than 3 months ago. A homogenous scar area in each patient was divided into two equal parts. One part was treated with transcutaneous sharp needle autologous fat grafting, the adjacent part with transcutaneous saline injection as control. Results were evaluated by clinical assessment with scar scale questionnaires, histological examination, and objective scar assessment with Cutometer, Mexameter, Tewameter and Corneometer.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Masking Description

2 skin zones per participant, A and B, 1 is treated, 1 is placebo coin toss determines which zone will be treated, this information is kept in sealed envelope

Eligibility Criteria

Ages
25 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •early skin-grafted deep burn scars
  • •otherwise healthy

Exclusion Criteria

  • •concomitant disease

Arms & Interventions

1 group of 15 patients

Experimental

procedure/surgery: fat grafting injection of scar

Intervention: lipofilling/ fat grafting (Procedure)

Same group of 15 patients

Experimental

procedure/surgery: placebo injection of scar

Intervention: placebo injection (Procedure)

Outcomes

Primary Outcomes

improvement of scar quality by physiological testing with cutometer

Time Frame: 6 months, 1 year

measures elasticity of the scar; micrometer; higher values better outcome

Improvement of scar quality by subjective evaluation with numerical Vancouver Scar Scale

Time Frame: 1 year

numerical score 0 to 13; ranges vascularity, height/thickness, pliability, and pigmentation

Improvement of scar quality by histological assessment

Time Frame: 6 months

histology of scar tissue, scoring by 2 independent blinded anatomopathologists, (numerical scoring of fibroblast activity, collagen and elastin organisation, vascularity) scoring range min 1(close to normal tissue) - 3 (scar characteristics)

physiological testing of scar tissue by corneometer

Time Frame: 6 months, 1 year

measures hydration of the epidermis; corneometer units, higher values better outcome

Improvement of scar quality by subjective evaluation with numerical POSAS (Patient and Observer Scar Assessment Scale) Scale

Time Frame: 1 year

numerical score 5 to 50: VSS plus surface area; patient assessments of pain, itching, color, stiffness, thickness, relief

improvement of scar quality by physiological testing with TEWA-meter (Trans Epidermal Water Loss-meter)

Time Frame: 6 months, 1 year

measures transepidermal water loss; g/m2/h; higher values worse outcome

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Phillip Blondeel

Clinical Professor, Head of Plastic Surgery, Principal Investigator

University Hospital, Ghent

Similar Trials